Pro: Fresh versus frozen embryo transfer. Is frozen embryo transfer the future?

低温保存 胚胎移植 活产 怀孕 随机对照试验 玻璃化 胚胎冷冻保存 胚胎 更安全的 妊娠率 产科 医学 妇科 男科 生物 外科 计算机科学 细胞生物学 遗传学 计算机安全
作者
Christos A. Venetis
出处
期刊:Human Reproduction [Oxford University Press]
卷期号:37 (7): 1379-1387 被引量:4
标识
DOI:10.1093/humrep/deac126
摘要

Embryo cryopreservation has been an integral part of ART for close to 40 years and vitrification has boosted overall ART efficacy and safety. Recently, there has been a vivid scientific discussion on whether elective cryopreservation of all embryos (freeze-all) should be pursued for most patients, with a fresh embryo transfer taking place only in selected cases. In terms of efficacy, the available evidence suggests that the freeze-all strategy leads to higher live birth rates after the first embryo transfer compared to the conventional strategy in high responders, while there is no difference in normal responders. There is no evidence to suggest that the freeze-all strategy is inferior to the conventional strategy of fresh transfer when comparing cumulative live birth rates using data from all available randomized controlled trials. The incidence of ovarian hyperstimulation syndrome is significantly reduced in the freeze-all policy. However, regarding obstetric complications and neonatal outcomes, the evidence suggests that each strategy is associated with certain risks and, therefore, there is no approach that could be unequivocally accepted as safer. Similarly, limited evidence does not support the notion that patients would be universally against freeze-all owing to the inevitable delay in pregnancy achievement. Finally, the cost-effectiveness of freeze-all is likely to vary in different settings and there have been studies supporting that this policy can be, under certain conditions, cost-effective. Adoption of the freeze-all policy can also allow for more flexible treatment strategies that have the potential to increase efficacy, reduce cost and make treatment easier for patients and clinics. Importantly, freeze-all does not require the use of any experimental technologies, further training of personnel or the costly acquisition of new equipment. For these reasons, transitioning to the freeze-all policy for most patients appears to be the next logical step in ART.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Minhuky完成签到 ,获得积分10
1秒前
SDW完成签到,获得积分10
3秒前
Xxxnnian完成签到,获得积分20
3秒前
焱小呆完成签到,获得积分10
3秒前
奥特曼完成签到 ,获得积分10
3秒前
Y20发布了新的文献求助10
4秒前
阿大呆呆应助让我静静采纳,获得30
5秒前
小皮皮她爹完成签到,获得积分10
5秒前
Liu完成签到,获得积分10
5秒前
5秒前
研友_842M4n发布了新的文献求助10
5秒前
香风智乃完成签到,获得积分10
5秒前
852应助xzh086采纳,获得10
6秒前
云云完成签到,获得积分10
6秒前
6秒前
莹莹王完成签到,获得积分20
7秒前
10秒前
十倍沉关注了科研通微信公众号
10秒前
天天快乐应助七兮采纳,获得10
11秒前
11秒前
细心的文轩完成签到 ,获得积分10
11秒前
13秒前
13秒前
ZZ完成签到,获得积分10
13秒前
曾经天德发布了新的文献求助30
14秒前
毛豆完成签到,获得积分10
14秒前
2183179a发布了新的文献求助10
14秒前
阔达真完成签到,获得积分10
14秒前
甄不错完成签到,获得积分10
14秒前
14秒前
Muggle完成签到,获得积分10
15秒前
yyj完成签到,获得积分10
16秒前
猩猩完成签到,获得积分10
17秒前
terrell应助阿伟采纳,获得10
18秒前
大个应助和敬清寂采纳,获得10
18秒前
友好南珍发布了新的文献求助10
19秒前
SID发布了新的文献求助10
19秒前
xzh086发布了新的文献求助10
19秒前
深情安青应助七兮采纳,获得10
20秒前
搜集达人应助跌跌撞撞采纳,获得10
20秒前
高分求助中
The three stars each : the Astrolabes and related texts 1070
Manual of Clinical Microbiology, 4 Volume Set (ASM Books) 13th Edition 1000
Boris Pesce - Gli impiegati della Fiat dal 1955 al 1999 un percorso nella memoria 500
[Lambert-Eaton syndrome without calcium channel autoantibodies] 500
少脉山油柑叶的化学成分研究 500
Recherches Ethnographiques sue les Yao dans la Chine du Sud 500
Aspect and Predication: The Semantics of Argument Structure 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2402485
求助须知:如何正确求助?哪些是违规求助? 2101772
关于积分的说明 5301162
捐赠科研通 1829381
什么是DOI,文献DOI怎么找? 911724
版权声明 560365
科研通“疑难数据库(出版商)”最低求助积分说明 487396